Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nurix Therapeutics, Inc. - Common stock
(NQ:
NRIX
)
17.43
-0.06 (-0.34%)
Official Closing Price
Updated: 4:15 PM EST, Jan 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nurix Therapeutics, Inc. - Common stock
< Previous
1
2
3
4
5
Next >
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
December 24, 2025
Issued on behalf of GT Biopharma, Inc.
From
Equity Insider
Via
GlobeNewswire
13 Analysts Have This To Say About Nurix Therapeutics
↗
November 04, 2025
Via
Benzinga
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
October 22, 2025
San Francisco, CA – October 22, 2025 – Nurix Therapeutics (NASDAQ: NRIX) has captured significant market attention, with its stock experiencing a notable surge following the announcement of the...
Via
MarketMinute
Nurix Stock Falls After-Hours After Wider Q3 Loss; Oppenheimer Sees FDA Support For Bexo, Retail Buys The Dip
↗
October 09, 2025
Via
Stocktwits
Breaking Down Nurix Therapeutics: 5 Analysts Share Their Views
↗
October 10, 2025
Via
Benzinga
Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
October 10, 2025
Via
Benzinga
Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
↗
October 10, 2025
Via
Benzinga
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday
↗
October 10, 2025
US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.
Via
Benzinga
8 Analysts Have This To Say About Nurix Therapeutics
↗
January 29, 2025
Via
Benzinga
Decoding 9 Analyst Evaluations For Nurix Therapeutics
↗
December 06, 2024
Via
Benzinga
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts
↗
November 06, 2024
Via
Benzinga
NURIX THERAPEUTICS INC (NASDAQ:NRIX) Misses Q3 2025 Estimates, Shares Drop
↗
October 09, 2025
Nurix Therapeutics Q3 2025 results miss revenue and EPS estimates, triggering a stock drop. The biotech firm also announced pivotal trial plans for its lead drug candidate.
Via
Chartmill
6 Analysts Assess Nurix Therapeutics: What You Need To Know
↗
July 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 17, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Thursday?
↗
July 17, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts
↗
July 14, 2025
Via
Benzinga
Amazon To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
↗
July 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 10, 2025
Via
Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
↗
July 10, 2025
Via
Benzinga
Nurix Therapeutics Posts Better-Than-Expected Q2 Results; Revenue Soars on Sanofi and Gilead Payments
↗
July 09, 2025
The company also shared promising early data from its blood cancer drug bexobrutideg and said it plans to begin late-stage trials later this year.
Via
Stocktwits
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 09, 2025
Via
Benzinga
What's going on in today's after hours session
↗
July 09, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
↗
June 02, 2025
Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.
Via
Benzinga
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views
↗
April 29, 2025
Via
Benzinga
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs
↗
April 23, 2025
On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.
Via
Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts
↗
April 02, 2025
Via
Benzinga
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock
↗
March 17, 2025
Via
Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
↗
October 31, 2024
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.
Via
Benzinga
Topics
ETFs
Stocks
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
↗
October 14, 2024
Via
Benzinga
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
↗
October 14, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
